Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 9Nausea 7Vomiting 6Lymphoma, Non-Hodgkin 6Multiple Myeloma 5Sezary Syndrome 4Leukemia 4Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Myeloproliferative Disorders 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Neutrophilic, Chronic 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Hairy Cell 3Hodgkin Disease 3Burkitt Lymphoma 3Testicular Neoplasms 2Neuroblastoma 2Neoplasms, Plasma Cell 2Neoplasms 2

Interventions

Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Post-Dural Puncture Headache × Aprepitant × Lymphoid × Clear all
NCT02347878 2015-01-27

Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)

Sun Yat-sen University

Phase 4 Unknown
85 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Post-Dural Puncture Headache

Data powered by HemOnc (CC BY 4.0) Colophon âš¡